Core Viewpoint - Medline Inc. will present at the J.P. Morgan Healthcare Conference on January 13, 2026, highlighting its position in the healthcare sector [1]. Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, based on total net sales of med-surg products [3]. - The company operates a broad product portfolio and resilient supply chain, aiming to improve clinical, financial, and operational outcomes for healthcare providers [3]. - Medline is headquartered in Northfield, Illinois, employs over 43,000 people globally, and operates in more than 100 countries [3]. Event Details - The presentation by Medline's CEO and CFO will be available on the company's Investor Relations website, with a replay accessible for 30 days post-event [2].

Core Insights - The First Trust U.S. Equity Opportunities ETF (FPX) is establishing itself as a leader for newly public companies by being the first ETF to include Medline Industries after its significant IPO [1][3] Group 1: ETF Performance and Strategy - FPX tracks the IPOX 100 U.S. Index, focusing on the 100 largest and most liquid U.S. IPOs and recent spin-offs, achieving approximately 40% growth this year and managing around $1.5 billion in assets [2] - The ETF employs a rules-based approach to systematically add newly public companies that meet liquidity and market-cap criteria, which reduces reliance on stock picking [3][4] Group 2: Market Context and Future Outlook - The current equity market environment is stabilizing, with expectations for a revival in IPO activity in 2026, supported by a positive trend noted by BNY [5] - FPX's method allows it to adapt to market cycles, capturing opportunities as new entrants emerge in the public markets [5] Group 3: Sector Exposure - The addition of Medline enhances FPX's exposure to the healthcare sector, which has historically performed well during reopening IPO cycles due to its defensive qualities and long-term growth potential [6]

Core Viewpoint - Medline, a major player in the medical supplies industry, successfully went public on NASDAQ with an initial offering price of $29, closing at $41, marking a first-day increase of over 40% and a market capitalization exceeding $66 billion (approximately 464.7 billion RMB) [2] Group 1 - Medline raised $6.26 billion in its IPO, making it the largest IPO globally in 2025 and one of the rare significant projects in the U.S. stock market since Rivian in 2021 [2] - Founded in 1966 by Jon Mills and Jim Mills in Illinois, Medline has focused on providing stable and controllable basic medical supplies to hospitals, including gauze, gloves, surgical gowns, and hospital beds [2] - In 2021, Blackstone, Carlyle, and Hellman & Friedman acquired control of Medline for approximately $34 billion, setting a record for the largest leveraged buyout at that time [2]

Group 1 - Medline Inc. had a successful IPO, with the stock price increasing over 41% on the first day of trading [1] - The company initially planned to sell 179 million shares at a price range of $26 to $30, but due to high demand, they sold over 216 million shares at $29 [1] - Medline opened trading at $35, which is more than 20% above the offer price, resulting in a market capitalization of approximately $54 billion [1] Group 2 - Medline Inc. supplies medical and surgical products to hospitals, surgery centers, and other healthcare facilities [1]

Group 1: Media and Entertainment - Warner Bros. has formally rejected Paramount's hostile bid to acquire the company, opting instead to focus on a partnership with Netflix, which boasts over 300 million subscribers [1] - The bidding war involving Warner Bros., Netflix, and ParamountSkydance has likely concluded with this decision [1] Group 2: Mergers and Acquisitions - IBM has acquired Confluent for $11 billion, indicating a significant move in the tech sector [2] - Medline's recent IPO raised a record $6.26 billion, with its stock surging over 40% on the first day of trading on Nasdaq [2] Group 3: Commodities Market - Oil prices reached a record low of $55 per barrel but recovered slightly, ending the week with a 1.4% decline [4] - Natural gas prices increased by 2.9% on Friday, although they remain 2.4% lower for the week [5] - Silver prices hit a new high of $67.385 per ounce, marking an 8.6% increase for the week and a 130% gain year-to-date [5] Group 4: Economic Indicators - The November non-farm payroll data showed no significant changes from September, while the Consumer Price Index for the 12 months ending in November was reported at 2.7%, down from 3% in September [6] - The S&P 500 closed 0.06% higher this week, while the Nasdaq Composite rose 0.3%, and the Dow Jones fell by 0.7% [7]

Group 1 - Medical supplies giant Medline (MDLN) priced its upsized IPO above the midpoint to raise $6.3 billion [2] - Two sizable IPOs were priced this week, along with seven SPACs [2] - A total of ten IPOs and eight SPACs submitted initial filings [2]

Core Insights - Medline Industries has made a significant impact on Wall Street by completing the largest US IPO of 2025, raising $6.26 billion, and marking the biggest stock debut in four years since Rivian's IPO in 2021 [1][3] - The company is now valued at approximately $54 billion after its stock closed over 40% higher on its first trading day [4] Company Overview - Medline is a major provider of medical-surgical products and supply chain solutions, with a catalog of 190,000 branded products and over 43,000 employees globally [5][9] - The company has a commitment to next-day delivery for 95% of its US customers, highlighting its extensive operational capabilities [9] IPO Details - The IPO initially planned to issue 179 million shares but was upsized to 216 million shares due to overwhelming demand, with an additional 30-day option for underwriters to purchase up to 32.4 million shares [5] - The proceeds from the IPO will be used to repay debt, cover general corporate purposes, and handle offering expenses, as Medline has a significant debt load from its 2021 leveraged buyout [6] Investor Participation - Notable investment firms have committed $2.35 billion to the IPO, including Morgan Stanley's Counterpoint Global, Baillie Gifford, and Singaporean sovereign wealth fund GIC Pte [7] Market Outlook - The successful IPO sets a positive tone for 2026, with potential public offerings from major companies like SpaceX and Anthropic anticipated [3]

Core Viewpoint - Embecta Corp. will present at the J.P. Morgan Healthcare Conference on January 14, 2026, showcasing its commitment to advancing insulin delivery and medical supplies [1]. Company Overview - Embecta is a global company with a 100-year legacy in insulin delivery, aiming to expand into a broad-based medical supplies company [2]. - The company employs approximately 2,000 individuals worldwide, focusing on innovative solutions and partnerships to improve lives [2].

Core Viewpoint - Medline Inc. has successfully completed its upsized initial public offering (IPO) of 248,439,654 shares of Class A common stock at a price of $29.00 per share, including the underwriters' option to purchase an additional 32,405,172 shares [1] Group 1: IPO Details - The proceeds from the issuance of 179,000,000 shares will be used to repay outstanding indebtedness under senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [2] - Medline plans to use proceeds from the issuance of 37,034,482 shares and the additional shares purchased by underwriters to buy or redeem an equivalent number of outstanding equity interests from certain pre-IPO owners [2] - The Class A common stock of Medline is listed on the Nasdaq Global Select Market under the symbol "MDLN" [2] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and lead bookrunning managers for the offering [2] - A wide range of firms, including Barclays, Citigroup, and Deutsche Bank Securities, served as bookrunning managers, while numerous others acted as co-managers for the offering [2] Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [5] - Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries [5]

RT Giacomo Tognini (@giacomotognini)Medical supplies giant Medline went public today in this year's biggest IPO. @DurotMatthew and I dug into public filings for @Forbes and found that 5 members of the Mills family-who founded Medline in 1966 and sold a majority in 2021-are now billionaires.https://t.co/2JiRnVAdct ...